Pub. Date : 2016
PMID : 27229742
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | CONCLUSIONS: The results suggest that third-line chemotherapy with combined bevacizumab and S-1 is safe and may delay the progression of mCRC resistant to oxaliplatin and irinotecan with mutated KRAS. | Irinotecan | proteasome 26S subunit, non-ATPase 1 | Homo sapiens |